Name | carnosol |
---|---|
Synonyms |
(7β)-11,12-Dihydroxy-7,20-epoxyabieta-8,11,13-trien-20-one
(7β)-11,12-Dihydroxy-7,20-epoxyabieta-8(14),9(11),12-trien-20-one 2H-9,4a-(Epoxymethano)phenanthren-12-one, 1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-, (4aR,9S,10aS)- Carnosol |
Description | Carnosol is a potent Ribosomal S6 Kinase (RSK2) inhibitor that could be useful for treating gastric cancer, with an IC50 of ~5.5 μM. |
---|---|
Related Catalog | |
Target |
IC50: 5.5 μM (RSK2)[1]. |
In Vitro | It is showed that carnosol has no cytotoxic effects on GES1 cells and 10 μM carnosol strongly suppresses RSK2 activity, but has little effect on any other kinase. Carnosol exerts strong dose-dependent inhibitory effects against RSK2 autophosphorylation and phosphorylation of its substrate ATF1[1]. |
In Vivo | Results indicate that Carnosol significantly decreaseS the volume and weight of gastric tumors relative to the vehicle-treated group. Additionally, mice tolerate treatment with carnosol without significant loss of body weight similar to the vehicle-treated group. The phosphorylation of CREB, a direct downstream protein of RSK2, Is strongly inhibited in the carnosol-treated group but the expression of total CREB is relatively unchanged[1]. |
Animal Admin | Mice[1] Mice are orally administrated Carnosol at 100 mg/kg or vehicle 5 times a week over a period of 31 days[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 524.8±50.0 °C at 760 mmHg |
Molecular Formula | C20H26O4 |
Molecular Weight | 330.418 |
Flash Point | 187.0±23.6 °C |
Exact Mass | 330.183105 |
PSA | 66.76000 |
LogP | 3.71 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.607 |
Storage condition | −20°C |
Precursor 1 | |
---|---|
DownStream 1 | |